ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

Society Growth continues, With OS The Largest; ASCO Plans to Reduce flow Of Medical Oncologists; AACR To Impose Page Charges for “Cancer Research:

May 31, 1985

NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not

July 3, 1981

Reasons NIH Women Scientists Leave: Family Roles, Lower Confidence.

November 2, 2007

Agricultural Pesticide Use Linked To Prostate Cancer

July 25, 2003

NCI Programs to Average Eight Percent Increase Over ’87 Under House Total, Bit Some Would Vary

August 14, 1987